These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 433389)

  • 1. [Viral hepatitis in patients on maintenance hemodialysis. The clinical characteristics, problems of epipemiology and nosology].
    Tareev EM; Ermolenko VM; Anan'ev VA; Golosova TV; Vorozhbieva TE
    Vestn Akad Med Nauk SSSR; 1979; (4):20-6. PubMed ID: 433389
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis B virus in a hemodialysis unit].
    Guma CL; Colombato LO; Alvarez E; Franco CO; Planes N
    Medicina (B Aires); 1985; 45(5):491-5. PubMed ID: 3842456
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 4. [Follow-up of chronic hepatitis B in patients with kidney transplantation: comparison between kidney transplant patients and hemodialysis patients].
    Markus R; Baumgarten R; Bartke D; Messerschmidt G
    Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):377-81. PubMed ID: 1615719
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical problems of chronic hepatitis].
    Bliuger AF
    Klin Med (Mosk); 1980 Sep; 58(9):16-23. PubMed ID: 6997608
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients.
    López-Alcorocho JM; Barril G; Ortiz-Movilla N; Traver JA; Bartolomé J; Sanz P; Selgas R; Carreño V
    J Med Virol; 2001 Feb; 63(2):103-7. PubMed ID: 11170045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viral hepatitis in Naples. Etio-epidemiologic aspects and problems deducted from a prospective study].
    Coltorti M; Del Vecchio-Blanco C; Caporaso N; Pignalosa G; Manzillo G; Maio G; Izzo CM
    Recenti Prog Med; 1983 May; 74(5):553-76. PubMed ID: 6612081
    [No Abstract]   [Full Text] [Related]  

  • 8. [Non-A, non-B hepatitis in patients with chronic hemodialysis].
    Bansky G; Grob PJ; Joller-Jemelka HI; Zaruba K; Iselin H; Gloor HJ
    Schweiz Med Wochenschr; 1984 Oct; 114(41):1423-7. PubMed ID: 6436969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HBsAG in feces, urine and saliva].
    Lento FG; Tandurella S
    G Batteriol Virol Immunol; 1979; 71(1-6):62-72. PubMed ID: 488577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis B surface antigen during the protracted course of viral hepatitis and chronic liver diseases].
    Belozerov ES; Sagandykov BB; Shabalin VV; Arkhipov GS
    Klin Med (Mosk); 1979 Jun; 57(6):80-4. PubMed ID: 459389
    [No Abstract]   [Full Text] [Related]  

  • 11. [Viral hepatitis in chronic hemodialysis and kidney transplantation].
    Degos F
    Gastroenterol Clin Biol; 1983 Nov; 7(11):923-9. PubMed ID: 6317506
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis G virus infection in hemodialysis patients from urban Delhi.
    Kumar D; Arora A; Singh NP; Kohli R; Kar P; Das BC
    Ren Fail; 2005; 27(1):87-93. PubMed ID: 15717640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
    Krishnamurthy G; Kher V; Naik S
    Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B and C viruses in pre-dialysis patients with chronic renal failure.
    Salako BL; Ayodele OE; Kadiri S; Arije A
    Afr J Med Med Sci; 2002 Dec; 31(4):311-4. PubMed ID: 15027769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and etiological study of chronic hepatitis and postnecrotic cirrhosis].
    Acuña R; Velasco M; Puelma E; Katz R; González M; Latorre R
    Rev Med Chil; 1985 Oct; 113(10):978-82. PubMed ID: 3837289
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation.
    Ponz E; Campistol JM; Barrera JM; Gil C; Pinto J; Andreu J; Bruguera M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1371-2. PubMed ID: 1846466
    [No Abstract]   [Full Text] [Related]  

  • 17. HBV DNA and other hepatitis B virus markers in sera from long-term hemodialysis and kidney transplant patients.
    Theilmann L; Gmelin K; Rambausek M; Dreikorn K; Bommer J; Kommerell B; Pfaff E
    Hepatogastroenterology; 1988 Aug; 35(4):147-50. PubMed ID: 3053386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of hepatitis B surface antigenemia (HBs Ag) in hemodialysis patients.
    Ribot S; Rothstein M; Goldblat M; Grasso M
    Arch Intern Med; 1979 Feb; 139(2):178-80. PubMed ID: 434972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of hemodialysis recirculating apparatuses in the spread of HBsAg at Czechoslovak hemodialysis centers].
    Opatrný K; Vodák M; Zichová M; Farník J; Mladá L; Opatrný K; Köcher P
    Vnitr Lek; 1982 Aug; 28(8):802-5. PubMed ID: 7135867
    [No Abstract]   [Full Text] [Related]  

  • 20. TT virus infection in patients on maintenance hemodialysis in Korea.
    Choi MS; Lee JH; Koh KC; Lee JH; Paik SW; Rhee PL; Rhee JC; Choi KW; Huh WS; Oh HY
    Hepatogastroenterology; 2003; 50(49):170-3. PubMed ID: 12630016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.